(Q51350287)

4 April 2018

title

The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patients (English)

1 reference

4 April 2018

1 reference

5

1 reference

4 April 2018

author name string

Benjamin Kasenda

1

1 reference

4 April 2018

Marcel Rehberg

2

1 reference

4 April 2018

Petra Thürmann

3

1 reference

4 April 2018

Melanie Franzem

4

1 reference

4 April 2018

Kristina Fritsch

6

1 reference

4 April 2018

Elisabeth Schorb

7

1 reference

4 April 2018

Jürgen Finke

8

1 reference

4 April 2018

Dirk Lebiedz

9

1 reference

4 April 2018

Gerald Illerhaus

10

1 reference

4 April 2018

publication date

29 March 2012

1 reference

4 April 2018

published in

Annals of Hematology

1 reference

4 April 2018

volume

91

1 reference

4 April 2018

issue

8

1 reference

4 April 2018

page(s)

1257-1264

1 reference

4 April 2018

Threshold Methotrexate Concentration for In Vivo Inhibition of DNA Synthesis in Normal and Tumorous Target Tissues

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

Therapeutic challenges in primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

Primary CNS lymphoma in immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

High dose methotrexate population pharmacokinetics and Bayesian estimation in patients with lymphoid malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

Relaxing the rule of ten events per variable in logistic and Cox regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

Methods to evaluate renal function in elderly patients: a systematic literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1441-2

10.1007/S00277-012-1441-2

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018